Delivery Order SPE2DB24D8002-SPE2DB25FJPKE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.94 to Dakota Drug, Inc. on September 23, 2025, for the supply of Cryselle-28 tablets. This firm fixed price delivery order will be completed by September 24, 2025, and will be performed in Anoka, Minnesota. The award carries no set-aside designation and represents a continuation of the DLA's medical supply procurement activities through existing contract vehicles. Dakota Drug, Inc., a self-certified small...
- This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2TM5, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,617.69 firm fixed-price delivery order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a period of performance through October 27, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order valued at $2,308.14 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 2, 2025. This Firm Fixed Price delivery order, issued without set-aside designation, represents a task order under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Qualipta 60 mg tablets in quantities of 30. The contract is valued at $3,263.50 with a firm fixed price structure and an ultimate completion date of June 2, 2025. This delivery order utilizes no set-aside designation and represents one of numerous pharmaceutical supply awards the vendor has received...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical products, medical supplies, and healthcare equipment, with a focus on supporting U.S. Armed Forces medical operations. The contract has a ceiling value of $3,151.10 and an ultimate completion date of May 8, 2025. It is part of the DLA Troop Support Medical's ECAT Generation...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,884.98 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of eluryng vaginal rings. This firm fixed price delivery order, issued on August 13, 2025, is set to be completed by August 14, 2025, and represents a continuation of services under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was not designated for any specific set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.22 to Dakota Drug, Inc. on August 25, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place in Anoka, Minnesota. The award utilized no set-aside designation and represents a straightforward pharmaceutical procurement from Dakota Drug, Inc., a self-certified small disadvantaged...
- The Defense Logistics Agency awarded a delivery order valued at $6,888.57 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100. This firm fixed-price delivery order, awarded on August 28, 2025, represents a single pharmaceutical supply requirement with a completion date of August 29, 2025. The award carries no set-aside designation and is being performed at the vendor's location in Anoka,...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJPKEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,399.60 to Dakota Drug, Inc. for the supply of Cryselle-28 tablets on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a pharmaceutical procurement supporting U.S. Armed Forces medical operations. The award was issued without a set-aside designation and is being performed in Anoka, Minnesota, where Dakota Drug, Inc. is headquartered. The vendor, a self-certified small disadvantaged business, has been registered in the System for Award Management since 2001 and specializes in supplying pharmaceutical products and medical equipment to federal agencies. This delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. The IDC, identified as SPE2DB24D8001, originated from solicitation SPE2DH-21-R-0002 and authorizes the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support military healthcare facilities. As a key supplier within the federal marketplace, Dakota Drug, Inc. has demonstrated significant capability in delivering diverse medications and medical products critical to defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/26/25 |